Schiff, M. H., Jaffe, J. S., & Freundlich, B. (2014). Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: Drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration. BMJ Publishing Group.
Citação norma ChicagoSchiff, Michael H., Jonathan S. Jaffe, and Bruce Freundlich. Head-to-head, Randomised, Crossover Study of Oral Versus Subcutaneous Methotrexate in Patients With Rheumatoid Arthritis: Drug-exposure Limitations of Oral Methotrexate At Doses ≥15 mg May Be Overcome With Subcutaneous Administration. BMJ Publishing Group, 2014.
MLA引文Schiff, Michael H., Jonathan S. Jaffe, and Bruce Freundlich. Head-to-head, Randomised, Crossover Study of Oral Versus Subcutaneous Methotrexate in Patients With Rheumatoid Arthritis: Drug-exposure Limitations of Oral Methotrexate At Doses ≥15 mg May Be Overcome With Subcutaneous Administration. BMJ Publishing Group, 2014.